Dolutegravir Impurity 10, with the CAS number 2384108-26-1, is a chemical compound associated with the antiretroviral drug dolutegravir, which is used in the treatment of HIV. As an impurity, it may arise during the synthesis or degradation of dolutegravir and is typically characterized by its molecular structure, which can include specific functional groups that differentiate it from the parent compound. The presence of impurities in pharmaceutical compounds is critical to monitor, as they can affect the efficacy, safety, and stability of the drug product. Generally, impurities are analyzed using techniques such as high-performance liquid chromatography (HPLC) or mass spectrometry to determine their concentration and impact. The characterization of Dolutegravir Impurity 10 would involve understanding its chemical properties, such as solubility, stability under various conditions, and potential biological activity. Regulatory guidelines often dictate the acceptable levels of impurities in pharmaceutical formulations to ensure patient safety and drug quality.

Dolutegravir Impurity 10

2384108-26-1: Dolutegravir Impurity 10, with the CAS number 2384108-26-1, is a chemical compound associated with the antiretroviral drug dolutegravir, which is used in the treatment of HIV. As an impurity, it may arise during the synthesis or degradation of dolutegravir and is typically characterized by its molecular structure, which can include specific functional groups that differentiate it from the parent compound. The presence of impurities in pharmaceutical compounds is critical to monitor, as they can affect the efficacy, safety, and stability of the drug product. Generally, impurities are analyzed using techniques such as high-performance liquid chromatography (HPLC) or mass spectrometry to determine their concentration and impact. The characterization of Dolutegravir Impurity 10 would involve understanding its chemical properties, such as solubility, stability under various conditions, and potential biological activity. Regulatory guidelines often dictate the acceptable levels of impurities in pharmaceutical formulations to ensure patient safety and drug quality.

CAS 2384108-26-1

Dolutegravir Impurity 10

Dolutegravir Impurity 38

Ref: 4Z-D-093047

5-((2,4-Difluorobenzyl)carbamoyl)-3-methoxy-4-oxo-1-(2-oxoethyl)-1,4-dihydropyridine-2-carboxylic Acid

Ref: ST-EA-CP-D24067